GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 348 filers reported holding GUARDANT HEALTH INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $12,419,248 | -10.3% | 419,003 | +8.4% | 0.00% | 0.0% |
| Q2 2023 | $13,841,676 | +2492.1% | 386,639 | +3798.7% | 0.00% | – |
| Q3 2022 | $534,000 | +34.8% | 9,917 | +1.0% | 0.00% | – |
| Q2 2022 | $396,000 | +18.9% | 9,816 | +95.2% | 0.00% | – |
| Q1 2022 | $333,000 | -62.3% | 5,029 | -43.0% | 0.00% | – |
| Q4 2021 | $883,000 | +3.3% | 8,826 | +29.1% | 0.00% | – |
| Q3 2021 | $855,000 | -66.6% | 6,839 | -66.9% | 0.00% | -100.0% |
| Q2 2021 | $2,563,000 | -45.1% | 20,636 | -32.6% | 0.00% | -50.0% |
| Q1 2021 | $4,671,000 | -19.4% | 30,607 | -31.9% | 0.00% | 0.0% |
| Q4 2020 | $5,793,000 | -92.9% | 44,952 | -93.9% | 0.00% | -93.9% |
| Q3 2020 | $81,914,000 | +7.4% | 733,254 | -22.1% | 0.03% | 0.0% |
| Q2 2020 | $76,289,000 | -15.8% | 941,010 | -27.8% | 0.03% | -31.2% |
| Q1 2020 | $90,628,000 | -19.0% | 1,302,551 | -9.1% | 0.05% | +2.1% |
| Q4 2019 | $111,927,000 | +31.3% | 1,433,238 | +7.3% | 0.05% | +23.7% |
| Q3 2019 | $85,233,000 | -24.0% | 1,335,302 | +2.7% | 0.04% | -24.0% |
| Q2 2019 | $112,186,000 | +164.9% | 1,299,572 | +135.3% | 0.05% | +163.2% |
| Q1 2019 | $42,345,000 | +1179.7% | 552,187 | +527.2% | 0.02% | +850.0% |
| Q4 2018 | $3,309,000 | – | 88,034 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |